Skip to content

Laparoscopic Adrenalectomy for Large Adrenal Tumors.

Is There Anything New in the Field of Large Adrenal Tumors ?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03830593
Enrollment
102
Registered
2019-02-05
Start date
2019-02-07
Completion date
2019-07-05
Last updated
2019-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adrenal Adenoma, Adrenal Tumor

Keywords

endocrine surgery; laparoscopic adrenalectomy;

Brief summary

Laparoscopic adrenalectomy is the treatment of choice for the benign tumor of less than 6 cm. However, this is an ongoing debate that exact cut-off value of tumor size for LA. The aim of this study was to assess whether the size of the adrenal tumor affects preoperative and postoperative outcomes in patients undergoing laparoscopic transperitoneal adrenalectomy as well as to evaluate the learning curve.

Detailed description

From April 2010 to October 2018, preoperative and postoperative data of 107 patients who underwent LTA with adrenal mass were recorded prospectively and analyzed retrospectively. The inclusion criteria were all hormonally active adrenal lesions, detection of increases in size in \< 4 cm adrenal tumors on serial imaging, solitary adrenal metastases without evidence of local invasion, tumors size ≥ 4 cm, patients between the age of 18 and 80, and American Society of Anesthesiologists score (ASA) ≤ 3. The patients with adrenal masses that specified suspicion of malignancy on imaging such as local invasion, irregular tumor margins were evaluated as ineligible for LTA, and excluded in this study, were addressed to open surgery. Retroperitoneoscopic and laparoscopic partial adrenalectomies were also excluded from the study. Totally 102 patients were included in the study. The patients were allocated according to adrenal tumor size as \<6cm (group 1:76) and ≥ 6 cm (group 2: 26). The variables such as demographics, tumor size, and laterality, operation time, blood loss, per-operative and postoperative complications, length of hospital stay, final pathology result were compared between the two groups. In order to evaluate the learning curve, the patients were also classified into three consecutive groups including group A (1-25), group B (25-50), group C (51-75) and group D (76-102) according to the chronological order of their surgery. Variables including operation time, tumor size, blood loss, and hospital stay, and overall complications were used to investigate the learning curve.

Interventions

minimally invasive lateral transperitoneal adrenalectomy

Sponsors

Ondokuz Mayıs University
CollaboratorOTHER
Samsun Liv Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. all hormonally active adrenal lesions, 2. detection of increases in size in \< 4 cm adrenal tumors on serial imaging, 3. solitary adrenal metastases without evidence of local invasion, 4. tumors size ≥ 4 cm, 5. patients between the age of 18 and 80 6. American Society of Anesthesiologists score (ASA) ≤ 3.

Exclusion criteria

1. suspicion of malignancy on imaging such as local invasion, irregular tumor margins 2. Retroperitoneoscopic adrenalectomies 3. laparoscopic partial adrenalectomies

Design outcomes

Primary

MeasureTime frameDescription
Operation timeintraoperative (minute)time from onset to complete of operation
Blood lossintraoperativeamount of bleeding during surgery (milliliter)
hospitalization1 dayduration of postoperative hospital stay
Complication1 dayabnormal conditions during or after surgery

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026